Cargando…
SHP-1: the next checkpoint target for cancer immunotherapy?
The immense power of the immune system is harnessed in healthy individuals by a range of negative regulatory signals and checkpoints. Manipulating these checkpoints through inhibition has resulted in striking immune-mediated clearance of otherwise untreatable tumours and metastases; unfortunately, n...
Autores principales: | Watson, H. Angharad, Wehenkel, Sophie, Matthews, James, Ager, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264497/ https://www.ncbi.nlm.nih.gov/pubmed/27068940 http://dx.doi.org/10.1042/BST20150251 |
Ejemplares similares
-
Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
por: Ager, Ann, et al.
Publicado: (2016) -
Targeting cancer using KAT inhibitors to mimic lethal knockouts
por: Brown, James A.L., et al.
Publicado: (2016) -
Protein kinase C in cellular transformation: a valid target for therapy?
por: Tarafdar, Anuradha, et al.
Publicado: (2014) -
Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists
por: Hoyer, Inna, et al.
Publicado: (2013) -
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2015)